Alexandria, Minnesota, USA and Hoddesdon, UK -– Douglas Scientific and LGC

announced today that they have formalized an exclusive distribution agreement for the sale of

Douglas Scientific’s innovative Array Tape® Platform.

Under the terms of this agreement LGC will represent and distribute the existing and future Array

Tape laboratory automation platforms in Europe, Middle East and Africa.

The combination of disruptive lab automation and KASP™ genotyping assays and reagents, creates

a catalyst, driving laboratory productivity and the efficiencies required in genotyping laboratories

today.

“This relationship is more than extending the reach of our individual product offerings. It’s about the alignment of two compelling missions. Douglas Scientific exists to make the world a better place with laboratory innovation and LGC is committed to science for a safer world,” says Darren Cook,

Executive Vice President of Business Development and Strategy, Douglas Scientific, “If our

combined solution results in more food for a growing population, a safer food supply and

environment, and faster and less costly diagnostics, then we’ve achieved something much more

powerful than we could have independently.”

Giulio Cerroni, Managing Director, Genomics, LGC, comments, “LGC has a great history of working

with many diverse companies, consortiums and researchers globally, to increase the understanding

of genetic markers in medical research and plant science. Through this new agreement, LGC and

Douglas Scientific will further enhance our combined efforts to enable scientists worldwide to reach

their goals of feeding the world, curing the world and protecting the world.”

The Array Tape Platform is comprised of Nexar® liquid handling and assay processing system,

Soellex® PCR waterbath, Araya® detection, and the Intellics™ Software Suite. The instrumentation

enables end-point reactions in Array Tape with small volume reactions (1.6 ?L). Array Tape is a

continuous polymer strip, serially embossed with reaction wells in customized volumes and formats.

The platform is highly compatible with LGC’s KASP genotyping assays and reagents.

LGC’s high-throughput genomics services, offered from UK, US and German laboratories, utilize

their own proprietary sbeadex™ DNA extraction chemistry and laboratory-validated genotyping

assays, while also taking advantage of their patented fluorescence-based competitive allele-specific

PCR (polymerase chain reaction) technique, KASP.

KASP chemistry is an enabling technology that is utilized to genotype known polymorphisms such as

SNPS and InDels in the targeted DNA.LGC scientists have contributed significantly to the development of new genotyping technologies,making affordable projects accessible to a broad range of customers, independent of project size. To date, they have extracted DNA from over 10 million samples, as well as processed over 1 billion PCR reactions.

The combined technologies offered via this relationship will provide a fast, cost effective, and robust solution for high-throughput genetic analysis that significantly simplifies sample preparation,decreases cost per sample, and increases sample throughput. Together, Douglas Scientific and LGC’s Genomics Division will work with customers in the pharmaceuticals, agricultural

biotechnology, food, environment, government, academic, security and sports sectors to achieve

excellence in investigative, diagnostic and measurement science and to provide a disruptive and

complete solution for any high-throughput laboratories currently using PCR technologies.

www.DouglasScientific.com